Green tea: Seeking hope in a dose of nature
Posted by admin at 4:33 pm in News

The News Review:

- Green tea: Seeking hope in a dose of nature
- Raw apple cider vinegar
- New Risk Factor Gene For Rheumatoid Arthritis Identified
- Tracking down the causes of multiple sclerosis
- Key factor in eye disease identified
- Researchers aim to outflank AIDS virus

Green tea: Seeking hope in a dose of nature
Boston Herald
They found that high doses of green-tea extract can have a positive effect on Hudson’s type of cancer chronic lymphocytic leukemia (CLL). The saga of Daniel Hauser the 13-year-old Minnesota boy with Hodgkin’s lymphoma has sparked public debate over the value of natural medicine especially in cancer treatment. In labs at Mayo and elsewhere scientists are putting those same questions to the test training their microscopes on everything from shark cartilage to mistletoe and finding some surprising answers. At last count the National Institutes of Health’s center for complementary medicine had sponsored 47 cancer-related studies — on macrobiotic diets soy Reiki-energy healing yoga flaxseed self-hypnosis fish oil massage acupuncture and more. So far most have focused on how alternative therapies can help ease the pain or side effects of cancer treatment says Mary Jo Kreitzer director of the University of Minnesota’s Center for Spirituality and Healing. Studies that have looked for cancer-fighting properties have been disappointing she said.

Raw apple cider vinegar
Examiner.com
Hippocrates the father of medicine used it for its natural cleansing healing and energizing health qualities. The ancient Babylonians use it before him and the Samurai warriors in Japan drank it for strength and power. It’s been traced to Egyptians as far back as 3000 B. Julius Caesar’s army used ACV tonic to stay healthy and fight off disease.

New Risk Factor Gene For Rheumatoid Arthritis Identified
Science Daily (press release)
Today most markers that are used to identify genes represent variants that occur in more than five percent of the population. The next wave in genetic screening will have to include the variants that occur in less than one percent of the population. In addition to the Feinstein Institute part of the North Shore-LIJ Health System other centers that are part of the RA consortium include: the University of Texas MD Anderson Cancer Center; the Genetics and Genomics Branch of the National Institute of Arthritis Musculoskeletal and Skin Diseases; the Rowe Program in Genetics University of California at Davis; the Russell Medical Research Center for Arthritis Department of Medicine University of California San Francisco; Brigham and Women’s Hospital at Harvard Medical School; University of Colorado Denver School of Medicine; University of Nebraska Medical Center; Central Hospital in Finland; University of Pittsburgh Medical Center; University of Alabama at Birmingham; Mount Sinai Hospital; University Health Network in ntario Canada; and Celera. The work was supported by grants from the US National Institutes of Health N1-AR-2-2263 (P.

Tracking down the causes of multiple sclerosis
EurekAlert (press release)
It would appear that B cells play an unexpected role in the spontaneous development of multiple sclerosis and that particularly aggressive T cells are activated by different proteins. Furthermore a new animal model is helping the scientists to understand the emergence of the most common form of the disease in Germany. (Nature Medicine May 31 2009 & Journal of Experimental Medicine June 1 2009) Multiple Sclerosis (MS) poses enormous problems for both patients and doctors: it is the most common inflammatory disease of the central nervous system in our part of the world and often strikes patients at a relatively young age. In some patients it leads to severe disability. Moreover despite decades of research on MS the causes and course of the disease are still largely unclear. There is much evidence to support the fact that MS is triggered by an autoimmune reaction: immune cells that should actually protect the body against threats like viruses bacteria and tumours attack the body’s own brain tissue. New treatments now available can attenuate the harmful immune reaction and thus delay the progress of the disease.

Key factor in eye disease identified
Vancouver Sun
Neurobiochemist Mike Przemyslaw Sapieha and an international team of scientists reported Monday in an advance online edition of Nature Medicine how a novel receptor called GPR91 goes into overdrive to activate a wild growth of blood vessels in the eye. It?s the first study to show how oxygen-starved ganglion cells seeking nourishment ?will produce blood vessels to feed themselves? said Sapieha a researcher at Universite de Montreal and Ste. Justine Hospital and the study?s lead author. ?We found that GPR91 is a master regulator of blood vessel growth that?s involved in normal development? Sapieha said. ?Under normal conditions that?s a good thing.

Researchers aim to outflank AIDS virus
Globe and Mail
Unsuccessful at developing vaccines that the cause the body’s natural immune system to battle the virus researchers are testing inserting a gene into the muscle that can cause it to produce protective antibodies against HIV. The new method worked in mice and now has proved successful in monkeys too they reported Sunday in the online edition of the journal Nature Medicine. The team is led by Philip R. Johnson of the Children’s Hospital of Philadelphia. That doesn’t mean an AIDS vaccine for people is in the wings Dr.
Related from International-lifestyles: peration condom: PNG military steps in to halt AIDS spread

Leave a Comment